ENvue Medical, Inc. (FEED)
US — Healthcare Sector
Peers:
Automate Your Wheel Strategy on FEED
With Tiblio's Option Bot, you can configure your own wheel strategy including FEED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FEED
- Rev/Share 3.1278
- Book/Share 49.4668
- PB 0.0235
- Debt/Equity 0.0747
- CurrentRatio 0.8601
- ROIC -0.2058
- MktCap 1262300.0
- FreeCF/Share -8.8172
- PFCF -0.1668
- PE -0.286
- Debt/Assets 0.0583
- DivYield 0
- ROE -0.1168
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
FEED,
NAOV
Published: January 09, 2026 by: GlobeNewsWire
Sentiment: Neutral
Published: January 09, 2026 by: GlobeNewsWire
Sentiment: Neutral
The program will integrate the Company's clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes The program will integrate the Company's clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes
Read More
About ENvue Medical, Inc. (FEED)
- IPO Date 2025-12-12
- Website http://www.nanovibronix.com
- Industry Medical - Specialties
- CEO Doron Robert Besser
- Employees 31
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.